The pharmaceuticals wholesale and distribution market in Asia is traversing an exponential growth curve due to increasing demand for pharmaceutical products. The demand for pharmaceuticals has surged multifold because of the increasing prevalence of chronic diseases such as diabetes, cardiovascular diseases, and cancer in the region. Moreover, the expansion of e-commerce in Asia is giving a further boost to the market growth. In this special issue, we have focused on this niche market. The cover story of this issue features Sawa Group. Established in 2004, Sawa Group is ranked amongst the top three pharmaceutical distributors in the Iraqi market. The firm’s know-how and long years of expertise in the health and pharmaceutical sectors have helped the firm bag an average sales of around 180 Million USD and an impressive market share of 7 percent of the total Iraq Pharma market in MAT.Q2.2022 with 7 percent growth despite the decline of the total Iraqi pharmaceutical market by -7.28 percent.
Also featuring in the issue is Medservice Plus which has been an active and prominent name in the industry within the Republic of Kazakhstan. For more than 25 years, it has been a leader among pharmaceutical distributors with 14 operating branches and 18 infrastructure assets and has gained a strong reputation as a reliable and stable partner. It is a vertically integrated company with its own manufacturing, purchasing, logistics (warehousing and transportation), distribution, and retail arms. Reading on you will find more such stories.
Keeping abreast of the latest developments in this market, Asia Business Outlook has shortlisted the top companies that have proved their excellence through innovative approach. In a bid to fulfill the customer expectations and contribute to the market’s evolution with their result-oriented persistence, these companies are raising the bar of quality and delivery in this field.
Do send your feedback and suggestions.